Inhibikase Therapeutics (IKT) Shares Outstanding (Diluted) (2021 - 2026)
Inhibikase Therapeutics (IKT) Shares Outstanding (Diluted) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 255.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 106.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 64.41 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 210.89 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.51 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 25.05 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 556.90 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 138.28 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 217.35 Mn |
| 10 | Inhibikase Therapeutics | 420.72 Mn | 261.70 Mn | - | 174.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 174.57 Mn |
| Mar 31, 2026 | 172.31 Mn |
| Dec 31, 2025 | 98.31 Mn |
| Sep 30, 2025 | 90.05 Mn |
| Jun 30, 2025 | 90.01 Mn |
| Mar 31, 2025 | 89.54 Mn |
| Dec 31, 2024 | 23.71 Mn |
| Sep 30, 2024 | 8.88 Mn |
| Jun 30, 2024 | 7.54 Mn |
| Mar 31, 2024 | 6.34 Mn |
| Dec 31, 2023 | 5.33 Mn |
| Sep 30, 2023 | 5.34 Mn |
| Jun 30, 2023 | 5.23 Mn |
| Mar 31, 2023 | 4.59 Mn |
| Dec 31, 2022 | 4.20 Mn |
| Sep 30, 2022 | 4.20 Mn |
| Jun 30, 2022 | 4.20 Mn |
| Mar 31, 2022 | 4.20 Mn |
| Dec 31, 2021 | 3.03 Mn |
| Sep 30, 2021 | 4.19 Mn |